Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Bausch Health Companies

Bausch Health Companies Inc reported $175M in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
Amgen AMGN:US USD 2.03B 196M
ANI Pharmaceuticals ANIP:US USD 9.9M 8.07M
Bausch Health Companies Inc VRX:CN USD 175M 219M
Biogen BIIB:US USD 507.7M 192.2M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Catalent CTLT:US USD 138M 78M
Corcept Therapeutics CORT:US USD 14.85M 7.65M
Danaher DHR:US USD 1.79B 502M
Drreddys Laboratories RDY:US INR 12.38B 4.04B
Eli Lilly LLY:US USD 1.49B 342.4M
Endo International ENDP:US USD 3.46M 240.32M
Gilead Sciences GILD:US USD 1.7B 562M
Horizon Pharma HZNP:US USD 35.99M 137.94M
Nektar Therapeutics NKTR:US USD -134710000 82.24M
Pacira PCRX:US USD -20017000 10.12M
Perrigo PRGO:US USD 48.5M 17.5M
Phibro Animal Health PAHC:US USD 18.55M 2.71M
Revance Therapeutics RVNC:US USD -58032000 86.38M
Supernus Pharmaceuticals SUPN:US USD 5.18M 29.16M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M
Zoetis ZTS:US USD 697M 105M